Ampio Pharmaceuticals (FRA:APH0) Volatility: N/A% (As of Jun. 26, 2026)


FRA:APH0 Ampio Pharmaceuticals Inc FRA:APH0
35 GF Score
Price €3.62
View Full Analysis

What is Ampio Pharmaceuticals Volatility?

Ampio Pharmaceuticals FRA:APH0 35 Volatility is N/A% as of Jun. 26, 2026. GuruFocus rates FRA:APH0 with a GF Score™ of 35/100.

Volatility is a statistical measure of the dispersion of returns for a given security or market index, it shows how the price swings around its mean. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year. In most cases, the higher the volatility, the riskier the security.

Ampio Pharmaceuticals does not have enough data to calculate Volatility.


Ampio Pharmaceuticals  (FRA:APH0) Volatility Explanation

Volatility is a statistical measure of the dispersion of returns for a given security or market index. It’s often measured as standard deviation or variance of historical returns over a certain period. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year.

Volatility reflects the uncertainty or risk of a security’s value. Generally speaking, a higher volatility suggests a higher risk, because it implies a wider fluctuation around average price. This means the price of the security can change dramatically in either direction within a short period. Conversely, a lower volatility means that the security's price is more steady, which suggests a lower risk.

Another measurement of relative volatility is Beta. Beta is a measure of systematic risk of a security or a portfolio in comparison to the market as a whole. Beta is usually compared to 1. A beta of greater than 1 indicates that the security's price will be more volatile than the market.


Ampio Pharmaceuticals Volatility Related Terms


FRA:APH0 vs EFTR, VBIVQ, VRTX: Volatility Comparison

For the Biotechnology subindustry, Ampio Pharmaceuticals's Volatility, along with its competitors' market caps and Volatility data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ampio Pharmaceuticals Volatility vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ampio Pharmaceuticals's Volatility distribution charts can be found below:

* The bar in red indicates where Ampio Pharmaceuticals's Volatility falls into.


FRA:APH0
35GF Score
Ampio Pharmaceuticals Inc FRA:APH0
Volatility is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ampio Pharmaceuticals  (FRA:APH0) Volatility Calculation

The annualized volatility is calculated as following:

σA=σM * 12
= 1/(n-1) ∑(Ri - R')^2 * 12

Where: σM is the monthly volatility, n is the number of months in the period, Ri is the security's historical monthly returns and R' is the arithmetic mean of monthly returns.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Volatility →
What does a Volatility of N/A% mean?
Ampio Pharmaceuticals (FRA:APH0) has a Volatility of N/A% as of Jun. 26, 2026. Volatility is measured as the annualized standard deviation between monthly returns from the security over the past year. View historical data on Ampio Pharmaceuticals and its competitors.
Is Ampio Pharmaceuticals' Volatility too high?
Ampio Pharmaceuticals' current Volatility is N/A%. Overall, Ampio Pharmaceuticals has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Ampio Pharmaceuticals' Volatility compare to EFTR and VBIVQ?
Ampio Pharmaceuticals' Volatility of N/A% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Volatility for a Biotechnology company?
A good Volatility depends on the Biotechnology industry context. However, Volatility should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Volatility mean?
A high Volatility can signal that a stock is expensive relative to its fundamentals. Volatility is measured as the annualized standard deviation between monthly returns from the security over the past year. View historical data on Ampio Pharmaceuticals and its competitors. Ampio Pharmaceuticals's current Volatility is N/A%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ampio Pharmaceuticals stock overvalued right now?
Ampio Pharmaceuticals (FRA:APH0) has a current Volatility of N/A%. The current Volatility is N/A%. Ampio Pharmaceuticals' overall GF Score™ is 35/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Volatility calculated?
Volatility is calculated from a company's financial statements. For Ampio Pharmaceuticals (FRA:APH0), the current Volatility is N/A% as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ampio Pharmaceuticals Business Description

Address 9800 Mount Pyramid Court, Suite 400, Englewood, CO, USA, 80112
Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development of a potential treatment for osteoarthritis of the knee (OAK) as part of its OA-201 development program (OA-201 program or OA-201).
35GF Score

Get the complete analysis for FRA:APH0

Volatility is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.62
Price